Takami Sato
Director, Metastatic Uveal Melanoma Program · SIDNEY KIMMEL MEDICAL COLLEGE AT THOMAS JEFFERSON UNIVERSITY
Credentials: · · ·
History
PresentMetastatic Uveal Melanoma Program · SIDNEY KIMMEL MEDICAL COLLEGE AT THOMAS JEFFERSON UNIVERSITY
- 1983–1985
- 1980–1983
- 1976–1980
Research
JAMA · 2014 · 354 citations
CHECKPOINT INHIBITOR IMMUNE THERAPY: Systemic Indications and Ophthalmic Side Effects
Review · Retina · 2018 · 274 citations
Systematic review or meta-analysis · Annals of Oncology · 2019 · 237 citations
- MM
40 papers
- DB
26 papers
21 papers
21 papers · 2 as a fellow
- JS
17 papers
15 papers
15 papers
- RC
12 papers
Grants
- 2004–2008
Immunoembolization of the Hepatic Artery with (GM-CSF)
National Cancer Institute · R21
Contact PI · $579.3K · Thomas Jefferson University
Clinical trials
- 2018–2025
Nivolumab in Treating Patients With Stage IIB-IIC Melanoma That Can Be Removed by Surgery
Principal investigator · Completed · Phase 2
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- 2014–2026
Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma
Principal investigator · Active not recruiting · Phase 2
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- 2011–2024
SIR-Spheres® 90Y Microspheres Treatment of Uveal Melanoma Metastasized to Liver
Principal investigator · Completed · Phase 2
Thomas Jefferson University
- 2005–2009
Nausea and Vomiting In Patients Receiving Consecutive Days of Cisplatin
Principal investigator · Terminated
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University